Cocrystal Pharma (COCP) Prepaid Assets (2010 - 2026)

Cocrystal Pharma (COCP) reported Prepaid Assets of $418000.0 for Q1 2026, up 8.57% on a YoY basis from $385000.0 in Q1 2025, and up 27.44% sequentially from $328000.0 in Q4 2025.

Cocrystal Pharma (COCP) Prepaid Assets (2010 - 2026) Analysis & Trends

Cocrystal Pharma (COCP) has 17 years of Prepaid Assets data on file, last reported at $418000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 8.57% year-over-year to $418000.0; the trailing twelve-month figure through Mar 2026 stood at $418000.0 (up 8.57% YoY), and the FY2025 full-year result was $328000.0, down 23.72% from the prior year.
  • Prepaid Assets rose to $418000.0 in Q1 2026, from $328000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.8 million in Q3 2022 to a low of $282000.0 in Q2 2025.
  • A 5-year average of $1.1 million and a median of $509000.0 in 2024 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets jumped 322.13% in 2023 and plunged 82.28% in 2024, its largest moves.
  • Tracing COCP's Prepaid Assets over 5 years: stood at $2.2 million in 2022, then declined by 20.95% to $1.8 million in 2023, then slumped by 75.75% to $430000.0 in 2024, then decreased by 23.72% to $328000.0 in 2025, then grew by 27.44% to $418000.0 in 2026.
  • Business Quant data shows COCP's Prepaid Assets at $418000.0 in Q1 2026, $328000.0 in Q4 2025, and $465000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Cocrystal Pharma 12.57 Mn 7.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 418,000.00
Dec 31, 2025 328,000.00
Sep 30, 2025 465,000.00
Jun 30, 2025 282,000.00
Mar 31, 2025 385,000.00
Dec 31, 2024 430,000.00
Sep 30, 2024 509,000.00
Jun 30, 2024 365,000.00
Mar 31, 2024 1.57 Mn
Dec 31, 2023 1.77 Mn
Sep 30, 2023 1.84 Mn
Jun 30, 2023 2.06 Mn
Mar 31, 2023 2.22 Mn
Dec 31, 2022 2.24 Mn
Sep 30, 2022 2.77 Mn
Jun 30, 2022 488,000.00
Mar 31, 2022 560,000.00
Dec 31, 2021 568,000.00
Sep 30, 2021 747,000.00
Jun 30, 2021 225,000.00